http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102675303-B
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18086029ee284d70cc9ce46d117d4ff3 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate | 2011-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2014-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eae574ea2ed1edb9ee19985849297398 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c979712a8fdff4d1ae9d7de1509d7f7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db846a0d0c56a585797aa8d75663646b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_993e0656531d128011ae8491e5c9af2a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21bec6975318b2042c8b6791706f9743 |
publicationDate | 2014-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-102675303-B |
titleOfInvention | 4-alkyl-2-arylamino-5-(1,2,4-triazole-1-group) thiazole and application thereof to preparation of medicaments for resisting cancer |
abstract | The invention discloses 4-alkyl-2-arylamino-5-(1,2,4-triazole-1-group) thiazole and salts thereof shown in a formula I, wherein R is selected from H, alkyl groups of C1-C2 and straight-chain alkyl groups or branched-chain alkyl groups of C3-C4; X1, X2, X3, X4 and X5 are selected from hydrogen, alkyl groups of C1-C2, hydroxide group, methoxy group, oxyethyl group, trifluoromethyl, fluorine, chlorine, bromine, nitryl, amino group, acetyl amino group, methanesulfamide, ethoxycarbonyl or carboxyl; and the salts of the 4-alkyl-2-arylamino-5-(1,2,4-triazole-1-group) thiazole are selected from hydrochloride, hydrobromide, nitrate, sulfate, phosphate, mesylate, p-toluene sulfonate, tartrate, lactate or malate. The 4-alkyl-2-arylamino-5-(1,2,4-triazole-1-group) thiazole is applied to preparation of medicaments for resisting cervical cancer or lung neoplasms. |
priorityDate | 2011-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 85.